Sonrai Analytics awarded AI infrastructure to improve patient outcomes with Colorectal Cancer
Belfast-based AI data discovery company Sonrai Analytics is launching a cutting-edge architecture that will lead to faster and more effective discovery of key mechanisms and drivers within healthcare enabled by artificial intelligence.
The platform has been developed with the support of Dell Technologies, NVIDIA, Cancer Research UK and Innovate UK, the UK’s innovation agency.
Powered by Dell Technologies latest PowerEdge servers and NVIDIA GPUs, the purpose-built AI solution will empower Sonrai Analytics to train a huge volume of AI models.
This is also enabled by efficient Power and Cooling provided by APC Schneider and AIOps service partner Securelinx.
The infrastructure will allow for more complex algorithms and architectures to analyse data faster, speed-up discovery and unlock important insights that could lead to healthcare breakthroughs within the innovative test environment.
Sonrai Analytics, established in 2018 by Dr Darragh McArt and Deva Senevirathne, uses AI and deep learning to enable Contract Research Organisations (CROs), Biotech and Pharma to unlock critical information contained within Big Data.
Dr Darragh McArt, CEO of Sonrai Analytics, said: “The relationships developed with NVIDIA and Dell in the technology sphere are important to help promote and foster innovation, allowing Sonrai to really add value towards our discovery of patterns within disease.
“This cutting-edge hardware will help advance our Data Science and Deep Learning operations to the next level. It enables our team to apply AI on bigger datasets using state-of-the-art algorithms whilst also reaching optimal solutions faster.”
At present, large AI experiments can take days to complete. Datasets of hundreds of patients routinely contain terabytes of molecular and imaging data. As the size and complexity of the data sets continue to scale, so too will the analytical challenges that they pose.
Commenting on the launch of the platform, George Maybury, Public Sector Director at Dell Technologies Ireland and Northern Ireland, continued: “Performance, availability and scalability are key for innovative companies like Sonrai Analytics that are harnessing the power of AI to improve patient outcomes.
“With the latest next generation Dell EMC PowerEdge, the team at Sonrai Analytics will be able to analyse vast quantities of data at speed and accelerate the development of precision medicine.”
Craig Rhodes, EMEA Industry Lead, AI for Health and Life Sciences at NVIDIA, explained: “Data science workflows have traditionally been slow and cumbersom. Dell selected NVIDIA RTX GPUs to enable superior performance for end-to-end data science workflows in the healthcare field, where speed, efficiency and accuracy significantly impact patient outcomes.”
Dr David Crosby, Head of Prevention and Early Detection Research for Cancer Research UK, added: “This application of artificial intelligence to data from tissue-based and genomics-based approaches has the potential to identify which colorectal cancers may be at risk of recurrence and could aid in earlier detection of ‘born to be bad’ tumour types which may require additional treatment.”
The infrastructure has capacity to support many AI applications and one potential use is within a £7 million partnership with the world’s leading Biotech company Roche and the Northern Ireland Precision Medicine Centre through the ACTIONED programme, funded jointly by Innovate UK and Cancer Research UK.
The AI infrastructure has capacity to support our development of deep learning algorithms that could help transform the treatment of patients with colorectal cancer.
A message from the Editor:
Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.
In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.
Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.
With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.
You can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to newsletter.co.uk
With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit https://www.newsletter.co.uk/subscriptions now to sign up.